Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: Genomic Health Inc

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Genomic Health Inc since year 2005. Table 2 shows the detailed insider transactions of Genomic Health Inc since 2005. The reporting company's ticker symbol is GHDX. The reporting company's CIK number is 1131324.

The total value of stock buying since 2005 is $136,359,992. The total value of stock sales is $7,583,655. The total value of stock exercises is $43,801.


1 year stock price chart,   1 day stock price chart
opopp
opopopop

Figure 1. Monthly insider transaction values at Genomic Health Inc (GHDX) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • $64,066k

    $6,406k

    $640k

    $64k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at Genomic Health Inc (GHDX) in the past 24 months. See table 2 for insider transaction details.

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • $24.58

    $18.44

    $12.29

    $6.15



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Genomic Health Inc (GHDX).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-08 0 0 55,927 1,330,898 5,000 6,650
2008-07 0 0 16,629 341,144 0 0
2008-06 493,611 9,797,003 16,729 324,300 0 0
2008-05 0 0 16,629 314,165 0 0
2008-04 0 0 12,000 206,661 0 0
2008-03 0 0 16,629 320,829 0 0
2008-02 0 0 30,629 686,749 10,201 9,649
2008-01 0 0 16,629 411,398 0 0
2007-12 0 0 4,629 106,909 0 0
2007-11 0 0 11,284 253,850 0 0
2007-10 0 0 16,629 333,780 0 0
2007-09 0 0 40,629 799,617 0 0
2007-08 5,350 100,390 16,629 328,863 0 0
2007-07 0 0 16,629 342,237 0 0
2007-06 0 0 16,629 311,135 0 0
2007-05 4,000,143 64,066,162 16,629 274,924 0 0
2007-04 0 0 16,629 286,651 43,345 27,502
2007-03 628,786 11,484,603 16,629 304,356 0 0
2007-02 811,781 14,845,329 16,629 305,189 0 0
2006-12 953,338 19,286,642 0 0 0 0
2006-09 1,195,954 16,779,863 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for Genomic Health Inc (GHDX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-08-26 Baker Joffre (Chief Scientific Officer) Sale 4,629 22.69 105,048
2008-08-26 Shak Steven (Chief Medical Officer) Sale 5,000 22.93 114,673
2008-08-18 Cole G Bradley (EVP & CFO) Sale 9,298 23.67 220,116
2008-08-18 Cole G Bradley (EVP & CFO) Option Exercise 5,000 1.33 6,650
2008-08-15 Popovits Kimberly J (President and COO) Sale 12,500 24.08 300,953
2008-08-14 Popovits Kimberly J (President and COO) Sale 12,500 24.40 305,035
2008-08-12 Scott Randal W (Chief Executive Officer) Sale 6,000 23.93 143,590
2008-08-11 Scott Randal W (Chief Executive Officer) Sale 6,000 23.58 141,483
2008-07-15 Scott Randal W (Chief Executive Officer) Sale 6,000 21.19 127,167
2008-07-14 Scott Randal W (Chief Executive Officer) Sale 6,000 20.81 124,838
2008-07-01 Baker Joffre (Chief Scientific Officer) Sale 4,629 19.26 89,139
2008-06-24 Shak Steven (Chief Medical Officer) Sale 100 20.00 2,000
2008-06-10 Scott Randal W (Chief Executive Officer) Sale 6,000 19.83 118,972
2008-06-09 Scott Randal W (Chief Executive Officer) Sale 6,000 20.01 120,032
2008-06-09 Baker Felix (Director) Purchase 82,618 19.64 1,622,935
2008-06-06 Baker Felix (Director) Purchase 201,769 20.11 4,057,543
2008-06-05 Baker Felix (Director) Purchase 122,910 19.55 2,403,399
2008-06-02 Baker Joffre (Chief Scientific Officer) Sale 4,629 17.99 83,296
2008-05-13 Scott Randal W (Chief Executive Officer) Sale 6,000 18.69 112,111
2008-05-12 Scott Randal W (Chief Executive Officer) Sale 6,000 18.81 112,863
2008-05-08 Baker Joffre (Chief Scientific Officer) Sale 4,629 19.27 89,191
2008-04-15 Scott Randal W (Chief Executive Officer) Sale 6,000 17.57 105,398
2008-04-14 Scott Randal W (Chief Executive Officer) Sale 6,000 16.88 101,263
2008-03-11 Scott Randal W (Chief Executive Officer) Sale 6,000 18.38 110,269
2008-03-10 Scott Randal W (Chief Executive Officer) Sale 6,000 19.29 115,757
2008-03-05 Baker Joffre (Chief Scientific Officer) Sale 4,629 20.48 94,803
2008-02-26 Shak Steven (Chief Medical Officer) Sale 5,000 20.23 101,159
2008-02-19 Cohen Fred E (Director) Option Exercise 5,201 .58 2,999
2008-02-19 Cole G Bradley (EVP & CFO) Sale 9,000 22.58 203,263
2008-02-19 Cole G Bradley (EVP & CFO) Option Exercise 5,000 1.33 6,650
2008-02-12 Scott Randal W (Chief Executive Officer) Sale 6,000 22.85 137,073
2008-02-11 Scott Randal W (Chief Executive Officer) Sale 6,000 23.17 139,045
2008-02-11 Baker Joffre (Chief Scientific Officer) Sale 4,629 22.94 106,209
2008-01-15 Scott Randal W (Chief Executive Officer) Sale 6,000 26.20 157,182
2008-01-14 Scott Randal W (Chief Executive Officer) Sale 6,000 24.89 149,332
2008-01-02 Baker Joffre (Chief Scientific Officer) Sale 4,629 22.66 104,884
2007-12-03 Baker Joffre (Chief Scientific Officer) Sale 4,629 23.10 106,909
2007-11-27 Popovits Kimberly J (President and COO) Sale 6,655 22.00 146,410
2007-11-08 Baker Joffre (Chief Scientific Officer) Sale 4,629 23.21 107,440
2007-10-09 Scott Randal W (Chief Executive Officer) Sale 6,000 20.07 120,420
2007-10-08 Scott Randal W (Chief Executive Officer) Sale 6,000 20.25 121,500
2007-10-01 Baker Joffre (Chief Scientific Officer) Sale 4,629 19.84 91,860
2007-09-11 Scott Randal W (Chief Executive Officer) Sale 12,000 19.81 237,718
2007-09-10 Scott Randal W (Chief Executive Officer) Sale 12,000 19.58 234,958
2007-09-10 Baker Joffre (Chief Scientific Officer) Sale 4,629 19.57 90,603
2007-08-23 Goldberg Michael D (Director) Purchase 5,350 18.76 100,390
2007-08-15 Scott Randal W (Chief Executive Officer) Sale 6,000 19.79 118,740
2007-08-14 Scott Randal W (Chief Executive Officer) Sale 6,000 20.02 120,120
2007-08-08 Baker Joffre (Chief Scientific Officer) Sale 4,629 19.44 90,003
2007-07-18 Scott Randal W (Chief Executive Officer) Sale 6,000 21.20 127,200
2007-07-17 Scott Randal W (Chief Executive Officer) Sale 6,000 21.17 127,020
2007-07-02 Baker Joffre (Chief Scientific Officer) Sale 4,629 19.01 88,017
2007-06-19 Scott Randal W (Chief Executive Officer) Sale 6,000 19.30 115,800
2007-06-18 Scott Randal W (Chief Executive Officer) Sale 6,000 19.01 114,060
2007-06-01 Baker Joffre (Chief Scientific Officer) Sale 4,629 17.56 81,275
2007-05-30 Baker Felix (Director) Purchase 18,577 16.45 305,616
2007-05-29 Baker Felix (Director) Purchase 127,821 16.39 2,094,499
2007-05-25 Baker Felix (Director) Purchase 156,234 16.24 2,537,910
2007-05-24 Baker Felix (Director) Purchase 91,912 16.33 1,501,069
2007-05-23 Baker Felix (Director) Purchase 98,314 16.40 1,612,495
2007-05-22 Baker Felix (Director) Purchase 532,857 16.67 8,882,457
2007-05-21 Baker Felix (Director) Purchase 979,313 15.50 15,179,350
2007-05-08 Scott Randal W (Chief Executive Officer) Sale 6,000 16.31 97,841
2007-05-08 Baker Joffre (Chief Scientific Officer) Sale 4,629 16.31 75,512
2007-05-07 Scott Randal W (Chief Executive Officer) Sale 6,000 16.93 101,571
2007-04-30 Popovits Kimberly J (President & COO) Option Exercise 43,345 .63 27,502
2007-04-10 Scott Randal W (Chief Executive Officer) Sale 6,000 17.34 104,065
2007-04-09 Scott Randal W (Chief Executive Officer) Sale 6,000 17.20 103,170
2007-04-02 Baker Joffre (Chief Scientific Officer) Sale 4,629 17.16 79,416
2007-03-09 Baker Felix (Director) Purchase 239,817 18.35 4,402,863
2007-03-06 Scott Randal W (Chief Executive Officer) Sale 6,000 18.70 112,183
2007-03-05 Scott Randal W (Chief Executive Officer) Sale 6,000 18.00 107,995
2007-03-02 Baker Julian (Director) Purchase 10,818 18.02 194,984
2007-03-01 Baker Joffre (Chief Scientific Officer) Sale 4,629 18.18 84,178
2007-03-01 Baker Julian (Director) Purchase 65,408 17.96 1,174,600
2007-02-21 Myers Woodrow A Jr (Director) Purchase 2,000 19.63 39,260
2007-02-16 Baker Julian (Director) Purchase 36,200 18.49 669,213
2007-02-14 Baker Julian (Director) Purchase 100,200 18.39 1,843,171
2007-02-13 Scott Randal W (Chief Executive Officer) Sale 6,000 18.32 109,908
2007-02-13 Baker Julian (Director) Purchase 237,838 18.26 4,342,325
2007-02-12 Scott Randal W (Chief Executive Officer) Sale 6,000 17.91 107,475
2007-02-12 Baker Julian (Director) Purchase 30,970 17.89 554,127
2007-02-08 Baker Joffre (Chief Scientific Officer) Sale 4,629 18.97 87,806
2006-12-06 Baker Julian (Director) Purchase 48,172 21.58 1,039,660
2006-12-05 Myers Woodrow A Jr (Director) Purchase 10,000 21.97 219,700
2006-12-05 Baker Julian (Director) Purchase 98,691 22.55 2,225,105
2006-12-04 Baker Julian (Director) Purchase 47,158 20.58 970,600
2006-12-01 Baker Julian (Director) Purchase 536,901 19.63 10,538,184
2006-09-08 Baker Felix (Other) Purchase 535,600 14.14 7,575,766
2006-09-07 Baker Felix (Other) Purchase 100,000 13.42 1,342,036

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genomic Health Inc (symbol GHDX, CIK number 1131324) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.